Oasmia Pharmaceutical AB (publ) is a public limited liability company listed on NASDAQ Stockholm and the Frankfurt Stock Exchange and is governed by a number of laws and regulations. The most important of these are the Swedish Companies Act, the Swedish Annual Accounts Act, NASDAQ Stockholm’s Rule Book for Issuers and the Swedish Corporate Governance Code.
Management, guidance and internal control are divided between the shareholders (via the Annual General Meeting), the Board of Directors, the CEO and corporate management. Oasmia also works in accordance with the internal instructions and guidelines adopted by Oasmia’s Board and management team. In addition, Oasmia’s auditors are responsible for the external control of the company.